LPI (LP Information)' newest research report, the “IPV Vaccine Industry Forecast” looks at past sales and reviews total world IPV Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected IPV Vaccine sales for 2023 through 2029. With IPV Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IPV Vaccine industry.
This Insight Report provides a comprehensive analysis of the global IPV Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IPV Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global IPV Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IPV Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IPV Vaccine.
The global IPV Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for IPV Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for IPV Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for IPV Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key IPV Vaccine players cover GlaxoSmithKline Plc, Sanofi S.A, Serum Institute of India Pvt. Ltd., PT Bio Farma and AJ Vaccines, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of IPV Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Mahoney
MEF1
Saukett
Segmentation by application
Private Distribution Channel
Public Distribution Channel
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKline Plc
Sanofi S.A
Serum Institute of India Pvt. Ltd.
PT Bio Farma
AJ Vaccines
Key Questions Addressed in this Report
What is the 10-year outlook for the global IPV Vaccine market?
What factors are driving IPV Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IPV Vaccine market opportunities vary by end market size?
How does IPV Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global IPV Vaccine Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for IPV Vaccine by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for IPV Vaccine by Country/Region, 2018, 2022 & 2029 2.2 IPV Vaccine Segment by Type 2.2.1 Mahoney 2.2.2 MEF1 2.2.3 Saukett 2.3 IPV Vaccine Sales by Type 2.3.1 Global IPV Vaccine Sales Market Share by Type (2018-2023) 2.3.2 Global IPV Vaccine Revenue and Market Share by Type (2018-2023) 2.3.3 Global IPV Vaccine Sale Price by Type (2018-2023) 2.4 IPV Vaccine Segment by Application 2.4.1 Private Distribution Channel 2.4.2 Public Distribution Channel 2.5 IPV Vaccine Sales by Application 2.5.1 Global IPV Vaccine Sale Market Share by Application (2018-2023) 2.5.2 Global IPV Vaccine Revenue and Market Share by Application (2018-2023) 2.5.3 Global IPV Vaccine Sale Price by Application (2018-2023) 3 Global IPV Vaccine by Company 3.1 Global IPV Vaccine Breakdown Data by Company 3.1.1 Global IPV Vaccine Annual Sales by Company (2018-2023) 3.1.2 Global IPV Vaccine Sales Market Share by Company (2018-2023) 3.2 Global IPV Vaccine Annual Revenue by Company (2018-2023) 3.2.1 Global IPV Vaccine Revenue by Company (2018-2023) 3.2.2 Global IPV Vaccine Revenue Market Share by Company (2018-2023) 3.3 Global IPV Vaccine Sale Price by Company 3.4 Key Manufacturers IPV Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers IPV Vaccine Product Location Distribution 3.4.2 Players IPV Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for IPV Vaccine by Geographic Region 4.1 World Historic IPV Vaccine Market Size by Geographic Region (2018-2023) 4.1.1 Global IPV Vaccine Annual Sales by Geographic Region (2018-2023) 4.1.2 Global IPV Vaccine Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic IPV Vaccine Market Size by Country/Region (2018-2023) 4.2.1 Global IPV Vaccine Annual Sales by Country/Region (2018-2023) 4.2.2 Global IPV Vaccine Annual Revenue by Country/Region (2018-2023) 4.3 Americas IPV Vaccine Sales Growth 4.4 APAC IPV Vaccine Sales Growth 4.5 Europe IPV Vaccine Sales Growth 4.6 Middle East & Africa IPV Vaccine Sales Growth 5 Americas 5.1 Americas IPV Vaccine Sales by Country 5.1.1 Americas IPV Vaccine Sales by Country (2018-2023) 5.1.2 Americas IPV Vaccine Revenue by Country (2018-2023) 5.2 Americas IPV Vaccine Sales by Type 5.3 Americas IPV Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC IPV Vaccine Sales by Region 6.1.1 APAC IPV Vaccine Sales by Region (2018-2023) 6.1.2 APAC IPV Vaccine Revenue by Region (2018-2023) 6.2 APAC IPV Vaccine Sales by Type 6.3 APAC IPV Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe IPV Vaccine by Country 7.1.1 Europe IPV Vaccine Sales by Country (2018-2023) 7.1.2 Europe IPV Vaccine Revenue by Country (2018-2023) 7.2 Europe IPV Vaccine Sales by Type 7.3 Europe IPV Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa IPV Vaccine by Country 8.1.1 Middle East & Africa IPV Vaccine Sales by Country (2018-2023) 8.1.2 Middle East & Africa IPV Vaccine Revenue by Country (2018-2023) 8.2 Middle East & Africa IPV Vaccine Sales by Type 8.3 Middle East & Africa IPV Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of IPV Vaccine 10.3 Manufacturing Process Analysis of IPV Vaccine 10.4 Industry Chain Structure of IPV Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 IPV Vaccine Distributors 11.3 IPV Vaccine Customer 12 World Forecast Review for IPV Vaccine by Geographic Region 12.1 Global IPV Vaccine Market Size Forecast by Region 12.1.1 Global IPV Vaccine Forecast by Region (2024-2029) 12.1.2 Global IPV Vaccine Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global IPV Vaccine Forecast by Type 12.7 Global IPV Vaccine Forecast by Application 13 Key Players Analysis 13.1 GlaxoSmithKline Plc 13.1.1 GlaxoSmithKline Plc Company Information 13.1.2 GlaxoSmithKline Plc IPV Vaccine Product Portfolios and Specifications 13.1.3 GlaxoSmithKline Plc IPV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 GlaxoSmithKline Plc Main Business Overview 13.1.5 GlaxoSmithKline Plc Latest Developments 13.2 Sanofi S.A 13.2.1 Sanofi S.A Company Information 13.2.2 Sanofi S.A IPV Vaccine Product Portfolios and Specifications 13.2.3 Sanofi S.A IPV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Sanofi S.A Main Business Overview 13.2.5 Sanofi S.A Latest Developments 13.3 Serum Institute of India Pvt. Ltd. 13.3.1 Serum Institute of India Pvt. Ltd. Company Information 13.3.2 Serum Institute of India Pvt. Ltd. IPV Vaccine Product Portfolios and Specifications 13.3.3 Serum Institute of India Pvt. Ltd. IPV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Serum Institute of India Pvt. Ltd. Main Business Overview 13.3.5 Serum Institute of India Pvt. Ltd. Latest Developments 13.4 PT Bio Farma 13.4.1 PT Bio Farma Company Information 13.4.2 PT Bio Farma IPV Vaccine Product Portfolios and Specifications 13.4.3 PT Bio Farma IPV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 PT Bio Farma Main Business Overview 13.4.5 PT Bio Farma Latest Developments 13.5 AJ Vaccines 13.5.1 AJ Vaccines Company Information 13.5.2 AJ Vaccines IPV Vaccine Product Portfolios and Specifications 13.5.3 AJ Vaccines IPV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 AJ Vaccines Main Business Overview 13.5.5 AJ Vaccines Latest Developments 14 Research Findings and Conclusion